Literature DB >> 15337564

Use of the small pelvic field instead of the classic whole pelvic field in postoperative radiotherapy for cervical cancer: reduction of adverse events.

Kiyoshi Ohara1, Hajime Tsunoda, Toyomi Satoh, Akinori Oki, Shinji Sugahara, Hiroyuki Yoshikawa.   

Abstract

PURPOSE: We examined whether use of small pelvic (SP) field encompassing only the pericervical regions and upper stream lymphatic will reduce the adverse events that occur with classic whole pelvic (WP) field, in postoperative radiotherapy (RT) for cervical cancer. METHODS AND MATERIAL: This retrospective study included 72 patients treated with SP field (SP group) used specifically for node-negative status and 46 patients treated with WP field (WP group) used conventionally for node-positive status. Total dose was 50.0 or 50.4 Gy at 2.0 or 1.8 Gy per fraction. Acute adverse events (nausea, diarrhea, cystitis, and leukopenia) and late adverse events (lymphedema, cystitis, ileus, and diarrhea) were graded according to the Common Toxicity Criteria and compared between groups.
RESULTS: Diarrhea (Grades 2-3) and leukopenia (Grades 1-3) occurred significantly more often in WP group (32.4% and 80.5%, respectively) than in SP group (9.2% and 52.2%, respectively). Among the late events, lymphedema occurred most often overall (5-year rate: SP, 47.0%; WP, 49.1%). Only ileus occurred at a significantly higher rate in The WP group than in SP group (5-year rate: 16.2% vs. 3.2%).
CONCLUSIONS: Use of the SP field tailored for node-negative status was suggested to reduce adverse events involving the intestine and hemopoietic system.

Entities:  

Mesh:

Year:  2004        PMID: 15337564     DOI: 10.1016/j.ijrobp.2004.02.023

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer.

Authors:  Felix Zwicker; Benedict Swartman; Peter E Huber; Klaus Herfarth; Jürgen Debus; Henrik Hauswald
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06).

Authors:  Ji Hyeon Joo; Young Seok Kim; Byung Chul Cho; Chi Young Jeong; Won Park; Hak Jae Kim; Won Sup Yoon; Mee Sun Yoon; Ji-Yoon Kim; Jin Hwa Choi; Youngmin Choi; Joo-Young Kim
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

3.  Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.

Authors:  Goro Kasuya; Takafumi Toita; Kazuhisa Furutani; Takeshi Kodaira; Tatsuya Ohno; Yuko Kaneyasu; Ryouichi Yoshimura; Takashi Uno; Akira Yogi; Satoshi Ishikura; Masahiro Hiraoka
Journal:  Radiat Oncol       Date:  2013-06-08       Impact factor: 3.481

4.  Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.

Authors:  Mirela Mariana Roman; Romain Barbieux; Jean-Marie Nogaret; Pierre Bourgeois
Journal:  World J Surg Oncol       Date:  2018-04-10       Impact factor: 2.754

5.  The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China.

Authors:  Lingyun Yang; Jialing Yuan; Xi Zeng; Mingrong Xi; Hongjing Wang
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

6.  Post-operative small pelvic field radiation therapy in patients with intermediate risk early stage cervix cancer: a safe and efficient treatment modality.

Authors:  José Antonio Solis; Ilan Perrot Rosenberg; Jorge Olivares; Benjamin Tudela; Gabriel Veillon; Gabriel Lazcano
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.